Abstract
This article examines the clinical manifestations of and risk factors for cytomegalovirus (CMV). Prevention of CMV infection and disease are also explored. Antiviral resistance and management of CMV are examined.
Copyright (c) 2010 Elsevier Inc. All rights reserved.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Antiviral Agents / therapeutic use
-
Cytomegalovirus / pathogenicity
-
Cytomegalovirus Infections / drug therapy*
-
Cytomegalovirus Infections / transmission*
-
Disease Transmission, Infectious*
-
Hematopoietic Stem Cell Transplantation / adverse effects*
-
Humans
-
Immunocompromised Host*
-
Immunotherapy, Adoptive / methods
-
Virus Latency